Increasing Influenza and Tdap Vaccination of Pregnant Women

Completed · Not applicable

Conditions studied: Immunization; Infection, Pregnancy Related

In brief

Pregnant women who get influenza are more likely than non-pregnant women to have serious complications, including hospitalizations, death, preterm labor and premature birth. Pertussis can cause hospitalization or death for newborns. However, influenza and Tdap vaccination rates for pregnant women are low nationally. In this study, the investigators will perform a randomized controlled trial aimed at practice change in obstetricians' offices, with an overall goal of reducing morbidity and mortality from influenza and pertussis infections.

Key facts

Study ID

NCT04444518

Run by

University of Rochester

People needed

12760

Starts

2019-07-01

Expected to finish

2022-06-30

Last updated by the study team

2025-01-10

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients
• Sex is female
• Pregnant
• identified as being eligible for influenza or Tdap vaccine
• Providers
• any provider, nurse or staff associated with the participating sites

You may not qualify if…

• Patients
• none
• Providers
• none

Where it is running

• University of Rochester Medical Center (URMC) — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.